Cell entry mechanisms of SARS-CoV-2

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969 · see citing works

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · see citing works

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575 · see citing works

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · see citing works

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586 · see citing works

Virological assessment of hospitalized patients with COVID-2019

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661 · see citing works

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · see citing works

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · see citing works

Structural basis of receptor recognition by SARS-CoV-2

Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · see citing works

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · see citing works

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15562-9 · Cited by 3,097 · see citing works

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916 · see citing works

Structure, Function, and Evolution of Coronavirus Spike Proteins

Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740 · see citing works

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,631 · see citing works

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · see citing works

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031 · see citing works

Coronaviruses post-SARS: update on replication and pathogenesis

Perlman, S. M., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,766 · see citing works

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,649 · see citing works

High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2

Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200282 · Cited by 1,619 · see citing works

Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein

Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012) · Viruses · doi:10.3390/v4061011 · Cited by 1,368 · see citing works

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0305-x · Cited by 1,340 · see citing works

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., CHAIKEN, I. M., Fung, M. S. C., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889 · see citing works

Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis

Millet, J. K., & Whittaker, G. R. (2014) · Virus Research · doi:10.1016/j.virusres.2014.11.021 · Cited by 888 · see citing works

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15092 · Cited by 761 · see citing works

Neutralizing Antibody Responses to SARS-CoV-2 in a COVID-19 Recovered Patient Cohort and Their Implications

Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., Xia, S., Ling, Y., Zhang, Y., Xun, J., Lu, L., et al. (2020) · doi:10.1101/2020.03.30.20047365 · Cited by 754 · see citing works

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19

Chu, H., Chan, J. F., Wang, Y., Yuen, T. T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa410 · Cited by 659 · see citing works

Virus glycosylation: role in virulence and immune interactions

Vigerust, D. J., & Shepherd, V. L. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.03.003 · Cited by 593 · see citing works

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Gui, M., Song, W., Zhou, H., Xu, J., Chen, S., Xiang, Y., & Wang, X. (2016) · Cell Research · doi:10.1038/cr.2016.152 · Cited by 577 · see citing works

Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies

Li, F. (2014) · Journal of Virology · doi:10.1128/jvi.02615-14 · Cited by 574 · see citing works

Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence

Heald-Sargent, T. A., & Gallagher, T. (2012) · Viruses · doi:10.3390/v4040557 · Cited by 322 · see citing works

MERS-CoV spike protein: a key target for antivirals

Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F., & Jiang, S. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1271415 · Cited by 301 · see citing works

Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors

Hackbart, M., Deng, X., & Baker, S. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921485117 · Cited by 289 · see citing works

Receptor recognition and cross-species infections of SARS coronavirus

Li, F. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.014 · Cited by 269 · see citing works

The Canyon Hypothesis

Rossmann, M. G. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63732-9 · Cited by 226 · see citing works

SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission

Deming, M. E., Donaldson, E., & Baric, R. S. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.012 · Cited by 166 · see citing works

Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy

Das, S. R., Hensley, S. E., David, A., Schmidt, L., Gibbs, J. S., Puigbò, P., Ince, W. L., Bennink, J. R., & Yewdell, J. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108754108 · Cited by 143 · see citing works

Conformational States of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Ectodomain

Li, F., Berardi, M. J., Li, W., Farzan, M., Dormitzer, P. R., & Harrison, S. C. (2006) · Journal of Virology · doi:10.1128/jvi.02744-05 · Cited by 140 · see citing works

Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response

Dazert, E., Neumann‐Haefelin, C., Bressanelli, S., Fitzmaurice, K., Kort, J. C., Timm, J., McKiernan, S. M., Kelleher, D. P., Gruener, N. H., Tavis, J. E., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36587 · Cited by 123 · see citing works

Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines

Du, L., Tai, W., Yang, Y., Zhao, G., Zhu, Q., Sun, S., Liu, C., Tao, X., Tseng, C.-T. K., Perlman, S. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13473 · Cited by 120 · see citing works

Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation

Frieman, M. B., & Baric, R. S. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 116 · see citing works

Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity

VanBlargan, L. A., Goo, L., & Pierson, T. C. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00024-15 · Cited by 106 · see citing works

A Novel Activation Mechanism of Avian Influenza Virus H9N2 by Furin

Tse, L. V., Hamilton, A. M., Friling, T., & Whittaker, G. R. (2013) · Journal of Virology · doi:10.1128/jvi.02648-13 · Cited by 84 · see citing works

Lysosomal Proteases Are a Determinant of Coronavirus Tropism

Zheng, Y., Shang, J., Yang, Y., Liu, C., Wan, Y., Geng, Q., Wang, M., Baric, R. S., & Li, F. (2018) · Journal of Virology · doi:10.1128/jvi.01504-18 · Cited by 72 · see citing works

Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness

Sui, J., Deming, M. E., Rockx, B., Liddington, R., Zhu, Q. K., Baric, R. S., & Marasco, W. A. (2014) · Journal of Virology · doi:10.1128/jvi.02232-14 · Cited by 68 · see citing works

Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EMPreprint

Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.02.972927 · Cited by 59 · see citing works

Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages

Volk, A., Hackbart, M., Deng, X., Cruz-Pulido, Y. E., O’Brien, A., & Baker, S. C. (2020) · Journal of Virology · doi:10.1128/jvi.00178-20 · Cited by 39 · see citing works

Characteristics of SARS-CoV-2 and COVID-19

Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00459-7 · Cited by 5,291 · see citing works

Coronavirus biology and replication: implications for SARS-CoV-2

V’kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00468-6 · Cited by 3,175 · see citing works

Mechanisms of SARS-CoV-2 entry into cells

Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,082 · see citing works

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Huang, Y., Yang, C., Xu, X.-F., Xü, W., & Liu, S. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0485-4 · Cited by 2,207 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Zhang, L., Jackson, C. B., Mou, H., Ojha, A., Peng, H., Quinlan, B. D., Rangarajan, E. S., Pan, A., Vanderheiden, A., Suthar, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19808-4 · Cited by 1,387 · see citing works

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385 · see citing works

Neuropilin-1 is a host factor for SARS-CoV-2 infection

Daly, J. L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M. K., Antón-Plágaro, C., Shoemark, D. K., Simón-Gracia, L., Bauer, M., Hollandi, R., et al. (2020) · Science · doi:10.1126/science.abd3072 · Cited by 1,251 · see citing works

Mechanisms of SARS-CoV-2 Transmission and Pathogenesis

Harrison, A. G., Lin, T., & Wang, P. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.004 · Cited by 1,177 · see citing works

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Gilbert, P. B., Montefiori, D. C., McDermott, A. B., Fong, Y., Benkeser, D., Deng, W., Zhou, H., Houchens, C. R., Martins, K., Jayashankar, L., et al. (2022) · Science · doi:10.1126/science.abm3425 · Cited by 1,137 · see citing works

COVID-19 and comorbidities: Deleterious impact on infected patients

Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K. O. A., Ahmed, Z., & Younas, S. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.014 · Cited by 1,001 · see citing works

A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, A. G., Lorenc, A., del Molino del Barrio, I., Das, A., Fish, M., Monin, L., Muñoz-Ruiz, M., McKenzie, D. R., Hayday, T. S., Francos-Quijorna, I., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1038-6 · Cited by 946 · see citing works

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

Peacock, T. P., Goldhill, D. H., Zhou, J., Baillon, L., Frise, R., Swann, O. C., Kugathasan, R., Penn, R., Brown, J. C., Sanchez-David, R. Y., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00908-w · Cited by 770 · see citing works

COVID-19 and the human innate immune system

Schultze, J. L., & Aschenbrenner, A. C. (2021) · Cell · doi:10.1016/j.cell.2021.02.029 · Cited by 714 · see citing works

Effects of COVID-19 on the Nervous System

Iadecola, C., Anrather, J., & Kamel, H. (2020) · Cell · doi:10.1016/j.cell.2020.08.028 · Cited by 663 · see citing works

Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants

Qu, L., Yi, Z., Shen, Y., Lin, L., Chen, F., Xu, Y., Wu, Z., Tang, H., Zhang, X., Tian, F., et al. (2021) · doi:10.1101/2021.03.16.435594 · Cited by 636 · see citing works

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

Yang, L., Han, Y., Nilsson-Payant, B. E., Gupta, V., Wang, P., Duan, X., Tang, X., Zhu, J., Zhao, Z., Jaffré, F., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.015 · Cited by 632 · see citing works

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

Perico, L., Benigni, A., Casiraghi, F., Ng, L. F. P., Rénia, L., & Remuzzi, G. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00357-4 · Cited by 603 · see citing works

Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

Saito, A., Irie, T., Suzuki, R., Maemura, T., Nasser, H., Uriu, K., Kosugi, Y., Shirakawa, K., Sadamasu, K., Kimura, I., et al. (2021) · Nature · doi:10.1038/s41586-021-04266-9 · Cited by 600 · see citing works

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Wei, J., Alfajaro, M. M., DeWeirdt, P. C., Hanna, R. E., Lu-Culligan, W. J., Cai, W. L., Strine, M. S., Zhang, S.-M., Graziano, V. R., Schmitz, C. O., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.028 · Cited by 559 · see citing works

Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design

Malone, B., Urakova, N., Snijder, E. J., & Campbell, E. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00432-z · Cited by 538 · see citing works

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids

Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., et al. (2021) · Nature · doi:10.1038/s41586-020-2901-9 · Cited by 530 · see citing works

SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity

Ozono, S., Zhang, Y., Ode, H., Sano, K., Tan, T. S., Imai, K., Miyoshi, K., Kishigami, S., Ueno, T., Iwatani, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21118-2 · Cited by 513 · see citing works

The molecular virology of coronaviruses

Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J. M., & Glaunsinger, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013930 · Cited by 513 · see citing works

Regional and global contributions of air pollution to risk of death from COVID-19

Pozzer, A., Dominici, F., Haines, A., Witt, C., Münzel, T., & Lelieveld, J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa288 · Cited by 463 · see citing works

Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium

Jacob, F., Pather, S. R., Huang, W., Zhang, F., Wong, S. Z. H., Zhou, H., Cubitt, B., Fan, W., Chen, C. Z., Xu, M., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.016 · Cited by 430 · see citing works

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

Klein, S. L., Pekosz, A. S., Park, H.-S., Ursin, R. L., Shapiro, J. R., Benner, S. E., Littlefield, K. E., Kumar, S., Naik, H. M., Betenbaugh, M. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142004 · Cited by 424 · see citing works

SARS‐CoV‐2 endothelial infection causes COVID‐19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases

Colmenero, I., Santonja, C., Alonso, M., Noguera‐Morel, L., Hernández‐Martín, A., Martínez, D. A., Wiesner, T., Rodriguez-Peralto, J., Requena, L., & Torrelo, A. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19327 · Cited by 416 · see citing works

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens

Duan, L., Zheng, Q., Zhang, H., Niu, Y., Lou, Y., & Wang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576622 · Cited by 403 · see citing works

Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L

Sacco, M. D., Ma, C., Lagarias, P. I., Gao, A., Townsend, J. A., Meng, X., Dube, P. H., Zhang, X., Hu, Y., Kitamura, N., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe0751 · Cited by 401 · see citing works

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM

Xu, C., Wang, Y., Liu, C., Zhang, C., Han, W., Hong, X., Wang, Y., Qin, H., Wang, S., Zhao, Q., et al. (2020) · Science Advances · doi:10.1126/sciadv.abe5575 · Cited by 377 · see citing works

Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses

Song, W., Hui, C., Hull, J. H., Birring, S. S., McGarvey, L. P., Mazzone, S. B., & Chung, K. F. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00125-9 · Cited by 376 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity

Gobeil, S., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Stalls, V., Kopp, M., Manne, K., Li, D., Wiehe, K. J., et al. (2021) · Science · doi:10.1126/science.abi6226 · Cited by 375 · see citing works

COVID-19: Virology, biology and novel laboratory diagnosis

Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3303 · Cited by 371 · see citing works

ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation

Miao, G., Zhao, H., Li, Y., Ji, M., Chen, Y., Shi, Y., Bi, Y., Wang, P., & Zhang, H. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.010 · Cited by 354 · see citing works

TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells

Koch, J., Uckeley, Z. M., Doldan, P., Stanifer, M. L., Boulant, S., & Lozach, P. (2021) · The EMBO Journal · doi:10.15252/embj.2021107821 · Cited by 345 · see citing works

Sensing of COVID‐19 Antibodies in Seconds via Aerosol Jet Nanoprinted Reduced‐Graphene‐Oxide‐Coated 3D Electrodes

Ali, M. A., Hu, C., Jahan, S., Yuan, B., Saleh, M. S., Ju, E., Gao, S., & Panat, R. P. (2020) · Advanced Materials · doi:10.1002/adma.202006647 · Cited by 344 · see citing works

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

Bienvenu, L. A., Noonan, J. E., Wang, X., & Peter, K. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa284 · Cited by 337 · see citing works

COVID-19 and the Chemical Senses: Supporting Players Take Center Stage

Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 335 · see citing works

SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response

Huang, J., Hume, A. J., Abo, K. M., Werder, R. B., Villacorta-Martín, C., Alysandratos, K., Beermann, M. L., Simone-Roach, C., Lindstrom-Vautrin, J., Olejnik, J., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.013 · Cited by 330 · see citing works

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Hanke, L., Vidakovics, L. P., Sheward, D. J., Das, H., Schulte, T. P., Moliner-Morro, A., Corcoran, M., Achour, A., Hedestam, G. B. K., Hällberg, B. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18174-5 · Cited by 327 · see citing works

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Papa, G., Mallery, D. L., Albecka, A., Welch, L. G., Cattin‐Ortolá, J., Lupták, J., Paul, D., McMahon, H. T., Goodfellow, I., Carter, A. P., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009246 · Cited by 321 · see citing works

Senolytics reduce coronavirus-related mortality in old mice

Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., et al. (2021) · Science · doi:10.1126/science.abe4832 · Cited by 320 · see citing works

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

Gobeil, S., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Manne, K., Stalls, V., Kopp, M., Henderson, R. C., Edwards, R. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108630 · Cited by 320 · see citing works

The SARS-CoV-2 RNA–protein interactome in infected human cells

Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 320 · see citing works

COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies

Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S. A., Li, C., Kandimalla, M., Tang, X., Carmona, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 319 · see citing works

A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

Zhu, Y., Feng, F., Hu, G., Wang, Y., Yin, Y., Zhu, Y., Xü, W., Cai, X., Sun, Z., Han, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21213-4 · Cited by 303 · see citing works

A materials-science perspective on tackling COVID-19

Tang, Z., Kong, N., Zhang, X., Liu, Y., Hu, P., Mou, S., Liljeström, P., Shi, J., Tan, W., Kim, J. S., et al. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-00247-y · Cited by 302 · see citing works

Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence

Rahman, S., Montero, M. T. V., Rowe, K., Kirton, R., & Kunik, F. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1902303 · Cited by 299 · see citing works

SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium

Fodoulian, L., Tuberosa, J., Rossier, D., Boillat, M., Kan, C., Pauli, V., Egervari, K., Lobrinus, J. A., Landis, B. N., Carleton, A., et al. (2020) · doi:10.1101/2020.03.31.013268 · Cited by 286 · see citing works

COVID-19: A review of therapeutic strategies and vaccine candidates

Izda, V., Jeffries, M. A., & Sawalha, A. H. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108634 · Cited by 286 · see citing works

SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome

Zimmerman, M. I., Porter, J. R., Ward, M. D., Singh, S., Vithani, N., Meller, A., Mallimadugula, U. L., Kuhn, C. E., Borowsky, J. H., Wiewiora, R., et al. (2021) · Nature Chemistry · doi:10.1038/s41557-021-00707-0 · Cited by 282 · see citing works

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant

Zhang, J., Xiao, T., Cai, Y., Lavine, C. L., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A. K., Mayer, M. L., et al. (2021) · Science · doi:10.1126/science.abl9463 · Cited by 282 · see citing works

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner

Yamamoto, M., Kiso, M., Sakai‐Tagawa, Y., Iwatsuki‐Horimoto, K., Imai, M., Takeda, M., Kinoshita, N., Ohmagari, N., Gohda, J., Semba, K., et al. (2020) · Viruses · doi:10.3390/v12060629 · Cited by 278 · see citing works

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV‑2 Main Protease Inhibitors

Ma, C., Hu, Y., Townsend, J. A., Lagarias, P. I., Marty, M. T., Kolocouris, A., & Wang, J. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00130 · Cited by 273 · see citing works

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

Yeung, M. L., Teng, J. L. L., Jia, L., Zhang, C., Huang, C., Cai, J., Zhou, R., Chan, K., Zhao, H., Zhu, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.053 · Cited by 273 · see citing works

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies

Liu, Y., Soh, W. T., Kishikawa, J.-I., Hirose, M., Nakayama, E. E., Li, S., Sasai, M., Suzuki, T., Tada, A., Arakawa, A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.032 · Cited by 269 · see citing works

Monocytes and Macrophages in COVID-19

Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 269 · see citing works

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Richmond, P., Hatchuel, L., Dong, M., Ma, B., Hu, B. T., Smolenov, I. V., Li, P., Liang, P., Han, H. H., Liang, J. G., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00241-5 · Cited by 264 · see citing works

The SARS‐CoV‐2 main protease (M pro ): Structure, function, and emerging therapies for COVID‐19

Hu, Q., Xiong, Y., Zhu, G., Zhang, Y., Zhang, Y., Huang, P. C., & Ge, G. (2022) · MedComm · doi:10.1002/mco2.151 · Cited by 262 · see citing works

Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes

Ravindra, N. G., Alfajaro, M. M., Gasque, V., Huston, N. C., Wan, H., Szigeti-Buck, K., Yasumoto, Y., Greaney, A. M., Habet, V., Chow, R. D., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001143 · Cited by 258 · see citing works

mRNA vaccines in disease prevention and treatment

Zhang, G., Tang, T., Chen, Y., Huang, X., & Liang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01579-1 · Cited by 253 · see citing works

SARS-CoV-2 spreads through cell-to-cell transmission

Zeng, C., Evans, J. P., King, T., Zheng, Y.-M., Oltz, E. M., Whelan, S. P. J., Saif, L. J., Peeples, M. E., & Liu, S.-L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2111400119 · Cited by 246 · see citing works

Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro

Zhang, Q., Chen, C. Z., Swaroop, M., Xu, M., Wang, L., Lee, J., Wang, A. Q., Pradhan, M., Hagen, N. R., Chen, L., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00222-5 · Cited by 245 · see citing works

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Shapira, T., Monreal, I. A., Dion, S. P., Buchholz, D. W., Imbiakha, B., Olmstead, A. D., Jager, M. C., Désilets, A., Gao, G., Martins, M., et al. (2022) · Nature · doi:10.1038/s41586-022-04661-w · Cited by 239 · see citing works

Opposing activities of IFITM proteins in SARS‐CoV‐2 infection

Shi, G., Kenney, A. D., Kudryashova, E., Zani, A., Zhang, L., Lai, K. K., Hall‐Stoodley, L., Robinson, R., Kudryashov, D. S., Compton, A. A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020106501 · Cited by 235 · see citing works

Long-COVID postural tachycardia syndrome: an American Autonomic Society statement

Raj, S. R., Arnold, A. C., Barboi, A., Claydon, V. E., Limberg, J. K., Lucci, V.-E. M., Numan, M., Peltier, A., Snapper, H., Vernino, S., et al. (2021) · Clinical Autonomic Research · doi:10.1007/s10286-021-00798-2 · Cited by 227 · see citing works

Establishment of an African green monkey model for COVID-19 and protection against reinfection

Woolsey, C. B., Borisevich, V., Prasad, A., Agans, K., Deer, D., Dobias, N. S., Heymann, J., Foster, S., Levine, C. B., Medina, L. O., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00835-8 · Cited by 117 · see citing works

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

Dittmar, M., Lee, J. S., Whig, K., Segrist, E., Li, M., Kamalia, B., Castellana, L., Ayyanathan, K., Cardenas‐Diaz, F. L., Morrisey, E. E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108959 · Cited by 224 · see citing works

Accelerating antiviral drug discovery: lessons from COVID-19

von Delft, A., Hall, M. D., Kwong, A. D., Purcell, L. A., Saikatendu, K. S., Schmitz, U., Tallarico, J. A., & Lee, A. A. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00692-8 · Cited by 223 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

Synowiec, A., Szczepański, A., Barreto-Durán, E., Lie, L. K., & Pyrć, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 221 · see citing works

Impact of the delta variant on vaccine efficacy and response strategies

Bian, L., Gao, Q., Gao, F., Wang, Q., He, Q., Wu, X., Mao, Q., Xu, M., & Liang, Z. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1976153 · Cited by 219 · see citing works

COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts

John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219 · see citing works

Enzyme Therapy: Current Challenges and Future Perspectives

de la Fuente, M., Lombardero, L., Gómez-González, A., Solari, C., Angulo‐Barturen, Í., Acera, A., Vecino, E., Astigarraga, E., & Barreda‐Gómez, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179181 · Cited by 217 · see citing works

De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

Linsky, T. W., Vergara, R., Codina, N., Nelson, J. W., Walker, M. J., Su, W., Barnes, C. O., Hsiang, T.-Y., Esser-Nobis, K., Yu, K., et al. (2020) · Science · doi:10.1126/science.abe0075 · Cited by 216 · see citing works

SARS-COV-2 Variants: Differences and Potential of Immune Evasion

Hirabara, S. M., Serdan, T. D. A., Gorjão, R., Masi, L. N., Pithon‐Curi, T. C., Covas, D. T., Curi, R., & Durigon, E. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.781429 · Cited by 216 · see citing works

Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2

Baggen, J., Persoons, L., Vanstreels, E., Jansen, S., Looveren, D. V., Boeckx, B., Geudens, V., Man, J. D., Jochmans, D., Wauters, J., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00805-2 · Cited by 215 · see citing works

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation

Sanders, D. W., Jumper, C. C., Ackerman, P. J., Bracha, D., Donlic, A., Kim, H., Kenney, D., Castello-Serrano, I., Suzuki, S., Tamura, T., et al. (2021) · eLife · doi:10.7554/elife.65962 · Cited by 215 · see citing works

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination

Sternberg, A., & Naujokat, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118056 · Cited by 214 · see citing works

SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature

Fignani, D., Licata, G., Brusco, N., Nigi, L., Grieco, G. E., Marselli, L., Overbergh, L., Gysemans, C. A., Colli, M. L., Marchetti, P., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.596898 · Cited by 213 · see citing works

Host genetic factors determining COVID-19 susceptibility and severity

Velavan, T. P., Pallerla, S. R., Rüter, J., Augustin, Y. S., Kremsner, P. G., Krishna, S., & Meyer, C. G. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103629 · Cited by 213 · see citing works

The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics

Wu, W., Cheng, Y., Zhou, H. W., Sun, C., & Zhang, S. (2023) · Virology Journal · doi:10.1186/s12985-023-01968-6 · Cited by 213 · see citing works

Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface

Lu-Culligan, A., Chavan, A. R., Vijayakumar, P., Irshaid, L., Courchaine, E. M., Milano, K. M., Tang, Z., Pope, S. D., Song, E., Vogels, C. B. F., et al. (2021) · Med · doi:10.1016/j.medj.2021.04.016 · Cited by 212 · see citing works

An overview on the seven pathogenic human coronaviruses

Kesheh, M. M., Hosseini, P., Soltani, S., & Zandi, M. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2282 · Cited by 212 · see citing works

The glycosylation in SARS-CoV-2 and its receptor ACE2

Gong, Y., Qin, S., Dai, L., & Tian, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00809-8 · Cited by 207 · see citing works

Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art

Taleghani, N., & Taghipour, F. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112830 · Cited by 203 · see citing works

A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition

Dieterle, M. E., Haslwanter, D., Bortz, R. H., Wirchnianski, A. S., Lasso, G., Vergnolle, O., Abbasi, S. A., Fels, J. M., Laudermilch, E., Florez, C., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.020 · Cited by 202 · see citing works

IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

Bozzo, C. P., Nchioua, R., Volčič, M., Koepke, L., Krüger, J., Schütz, D., Heller, S., Stürzel, C. M., Kmieć, D., Conzelmann, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24817-y · Cited by 200 · see citing works

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Kremsner, P., Mann, P., Bosch, J., Fendel, R., Gabor, J. J., Kreidenweiss, A., Kroidl, A., Leroux-Roels, I., Leroux-Roels, G., Schindler, C., et al. (2020) · doi:10.1101/2020.11.09.20228551 · Cited by 199 · see citing works

Rapid and Efficient Detection of the SARS-CoV-2 Spike Protein Using an Electrochemical Aptamer-Based Sensor

Idili, A., Parolo, C., Álvarez-Diduk, R., & Merkoçi, A. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01222 · Cited by 198 · see citing works

ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress

Chen, D., Zheng, Q., Sun, L., Ji, M.-M., Li, Y., Deng, H., & Zhang, H. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.006 · Cited by 199 · see citing works

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration

Yang, Q., Hughes, T. A., Kelkar, A., Yu, X., Cheng, K., Park, S., Huang, W., Lovell, J. F., & Neelamegham, S. (2020) · eLife · doi:10.7554/elife.61552 · Cited by 196 · see citing works

Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity

Liu, H., Wu, N. C., Yuan, M., Bangaru, S., Torres, J., Caniels, T., van Schooten, J., Zhu, X.-Y., Lee, C. D., Brouwer, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.023 · Cited by 39 · see citing works

Enhanced binding of the N501Y‐mutated SARS‐CoV‐2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations

Luan, B., Wang, H., & Huynh, T. (2021) · FEBS Letters · doi:10.1002/1873-3468.14076 · Cited by 192 · see citing works

SARS-CoV-2 infection induces beta cell transdifferentiation

Tang, X., Uhl, S. A., Zhang, T., Xue, D., Li, B., Vandana, J. J., Acklin, J. A., Bonnycastle, L. L., Narisu, N., Erdos, M. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.05.015 · Cited by 192 · see citing works

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape

Tian, D., Sun, Y., Zhou, J., & Ye, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751778 · Cited by 192 · see citing works

A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)

Lee, J.-H., Choi, M., Jung, Y., Lee, S. K., Lee, C., Kim, J., Kim, J.-W., Kim, N. H., Kim, B., & Kim, H. G. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112715 · Cited by 191 · see citing works

Thiol-Mediated Uptake

Laurent, Q., Martinent, R., Lim, B., Pham, A., Kato, T., López‐Andarias, J., Sakai, N., & Matile, S. (2021) · JACS Au · doi:10.1021/jacsau.1c00128 · Cited by 191 · see citing works

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection

Bortolotti, D., Gentili, V., Rizzo, S., Schiuma, G., Beltrami, S., Strazzabosco, G., Fernández, M., Caccuri, F., Caruso, A., & Rizzo, R. (2021) · Microorganisms · doi:10.3390/microorganisms9091820 · Cited by 190 · see citing works

Molecular mechanisms of COVID-19

Li, F. (2022) · Acta Crystallographica Section A Foundations and Advances · doi:10.1107/s2053273322096759

Mechanisms of SARS-CoV-2 entry into cells

Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,082 · see citing works

The structural basis of accelerated host cell entry by SARS‐CoV‐2†

Seyran, M., Takayama, K., Uversky, V. N., Lundstrom, K. H., Palù, G., Sherchan, S. P., Attrish, D., Rezaei, N., Aljabali, A. A. A., Ghosh, S., et al. (2020) · FEBS Journal · doi:10.1111/febs.15651 · Cited by 159 · see citing works

SARS-CoV-2, Early Entry Events

CHAMBERS, J. K., Yu, J., Valdés, J. J., & Arulanandam, B. P. (2020) · Journal of Pathogens · doi:10.1155/2020/9238696 · Cited by 29 · see citing works

A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry

Shulla, A., Heald-Sargent, T. A., Subramanya, G., Zhao, J., Perlman, S. M., & Gallagher, T. (2010) · Journal of Virology · doi:10.1128/jvi.02062-10 · Cited by 686 · see citing works